MarketCapExport financials
CVR Partners, LP (UAN)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
CVR Partners, LP Balance Sheet 2025-2008 | UAN
Brief balance sheet overview of CVR Partners, LP
The review uses the five latest available annual reports between 2015 and 2019.
Assets rose from $536.3 million to $1.1 billion, a gain of +112.2%, while CAGR was about 20.7%. The balance sheet expanded rapidly.
Liabilities expanded faster than the asset base, +376.7% versus +112.2%. Debt-service capacity deserves attention.
Equity finances 36.9% of the balance sheet, compared with 71.9% at the start. The cushion remains adequate.
The net-debt-to-equity ratio is 1.42x. Borrowed funding is already a meaningful part of the structure.
Cash accounts for 3.3% of assets versus 9.3% initially. The change indicates the degree of financial flexibility.
Balance sheet takeaway
CVR Partners, LP's financial structure is not clear-cut. Asset scale alone does not resolve questions about how those assets are funded.
Annual Balance Sheet CVR Partners, LP
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
504 M | 481 M | 505 M | 463 M | 501 M | 607 M | 596 M | 567 M | 577 M | 568 M | 74.8 M | 45.1 M | 39.9 M | -2.8 M | -112 M | - | - | - |
Long Term Debt |
569 M | 568 M | 547 M | 547 M | 611 M | 634 M | 633 M | 629 M | 626 M | 623 M | 125 M | 125 M | 125 M | 125 M | 125 M | - | - | - |
Long Term Debt Current |
4.26 M | 4.04 M | 3.18 M | 2.93 M | 3.05 M | 3.31 M | 3.52 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
607 M | 614 M | 597 M | 563 M | 623 M | 642 M | 643 M | 632 M | 628 M | 624 M | 125 M | 125 M | 126 M | 127 M | 127 M | 3.89 M | - | - |
Total Current Liabilities |
96.8 M | 111 M | 75.5 M | 126 M | 162 M | 76.3 M | 75.5 M | 123 M | 56.1 M | 63 M | 25.9 M | 39.7 M | 27.4 M | 49.5 M | 42.5 M | 46.1 M | - | - |
Total Liabilities |
- | - | - | - | - | - | 718 M | 755 M | 684 M | 687 M | 151 M | 165 M | 154 M | 177 M | 170 M | - | - | - |
Deferred Revenue |
23 M | 50.8 M | 15.8 M | 47.5 M | 87.1 M | 30.6 M | 27.8 M | 68.8 M | 12.9 M | 12.6 M | 3.13 M | 13.6 M | 696 K | 965 K | 9.02 M | 18.7 M | - | - |
Total Assets |
969 M | 1.02 B | 975 M | 1.1 B | 1.13 B | 1.03 B | 1.14 B | 1.25 B | 1.23 B | 1.31 B | 536 M | 579 M | 594 M | 623 M | 659 M | 452 M | - | - |
Cash and Cash Equivalents |
69.2 M | 90.9 M | 45.3 M | 86.3 M | 113 M | 30.6 M | 37 M | 61.8 M | 49.2 M | 55.6 M | 50 M | 79.9 M | 85.1 M | 128 M | 237 M | 42.7 M | 5.44 M | 9.08 M |
Book Value |
969 M | 1.02 B | 975 M | 1.1 B | 1.13 B | 1.03 B | 420 M | 500 M | 550 M | 625 M | 386 M | 414 M | 440 M | 446 M | 490 M | 452 M | - | - |
Total Shareholders Equity |
266 M | 293 M | 303 M | 412 M | 342 M | 314 M | 420 M | 500 M | 550 M | 625 M | 386 M | 414 M | 440 M | 446 M | 489 M | 402 M | 520 M | 459 M |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet CVR Partners, LP
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
20 M | 20.2 M | 20.4 M | 20.6 M | 20.8 M | 21.1 M | 21.3 M | 20.1 M | 548 M | 548 M | 547 M | - | 547 M | 547 M | 547 M | 547 M | 547 M | 547 M | 546 M | 611 M | 625 M | 640 M | 635 M | 634 M | 635 M | 634 M | 633 M | 632 M | 632 M | 631 M | 630 M | 629 M | 628 M | 627 M | 627 M | 626 M | 625 M | 624 M | 624 M | 623 M | 623 M | 623 M | 623 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M |
Total Non Current Liabilities |
603 M | 606 M | 608 M | 607 M | 611 M | 611 M | 613 M | 614 M | 594 M | 596 M | 595 M | 597 M | 597 M | 598 M | 600 M | 563 M | 564 M | 562 M | 562 M | 623 M | 641 M | 654 M | 644 M | 642 M | 642 M | 641 M | 643 M | 643 M | 643 M | 643 M | 642 M | 632 M | 631 M | 630 M | 629 M | 628 M | 627 M | 626 M | 625 M | 624 M | 624 M | 624 M | 624 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 125 M | 126 M | 126 M | 126 M | 126 M | 127 M | 127 M | 127 M | 127 M | 127 M | 127 M | 127 M | 127 M |
Deferred Revenue |
68.1 M | 31.8 M | 23.6 M | 23 M | 35.9 M | 9.1 M | 36.9 M | 50.8 M | 39.3 M | 7.48 M | 19.8 M | 15.8 M | 39 M | 6.67 M | 44.9 M | 47.5 M | 64.7 M | 4.2 M | 80.9 M | 87.1 M | 33.8 M | 15.2 M | 40.4 M | 30.6 M | 11.6 M | 2.67 M | 37.6 M | 27.8 M | 16.4 M | 9.48 M | 65.4 M | 68.8 M | 31.6 M | 11.2 M | 24.2 M | 12.9 M | 19.4 M | 2.86 M | 31.9 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 3.13 M | 3.13 M | 3.13 M | 3.13 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 696 K | 696 K | 696 K | 696 K | 965 K | 965 K | 965 K | 965 K | 9.02 M | 9.02 M | 9.02 M | 9.02 M |
Total Assets |
1.06 B | 1.06 B | 1.02 B | 969 M | 1.04 B | 998 M | 1.01 B | 1.02 B | 987 M | 959 M | 972 M | 975 M | 1.02 B | 1.02 B | 1.12 B | 1.1 B | 1.08 B | 1.12 B | 1.1 B | 1.13 B | 1.07 B | 1.02 B | 1.03 B | 1.03 B | 1.05 B | 1.04 B | 1.13 B | 1.14 B | 1.18 B | 1.19 B | 1.25 B | 1.25 B | 1.22 B | 1.2 B | 1.24 B | 1.23 B | 1.28 B | 1.28 B | 1.33 B | 1.31 B | 1.31 B | 1.31 B | 1.31 B | 536 M | 536 M | 536 M | 536 M | 579 M | 579 M | 579 M | 579 M | 593 M | 593 M | 593 M | 593 M | 623 M | 623 M | 623 M | 623 M | 659 M | 659 M | 659 M | 659 M |
Cash and Cash Equivalents |
158 M | 137 M | 128 M | 69.2 M | 156 M | 114 M | 122 M | 90.9 M | 111 M | 47.5 M | 64.6 M | 45.3 M | 89.2 M | 68.7 M | 121 M | 86.3 M | 119 M | 156 M | 137 M | 113 M | 101 M | 42.8 M | 52.6 M | 30.6 M | 48.3 M | 32.6 M | 58 M | 37 M | 83.7 M | 69.3 M | 96.6 M | 61.8 M | 61.4 M | 28.3 M | 61.1 M | 49.2 M | 70 M | 51.6 M | 81.5 M | 55.6 M | 55.6 M | 55.6 M | 55.6 M | 50 M | 50 M | 50 M | 50 M | 79.9 M | 79.9 M | 79.9 M | 79.9 M | 85.1 M | 85.1 M | 85.1 M | 85.1 M | 128 M | 128 M | 128 M | 128 M | 237 M | 237 M | 237 M | 237 M |
Book Value |
1.06 B | 1.06 B | 1.02 B | 969 M | 1.04 B | 998 M | 1.01 B | 1.02 B | 987 M | 959 M | 972 M | 975 M | 1.02 B | 1.02 B | 1.12 B | 1.1 B | 1.08 B | 1.12 B | 1.1 B | 1.13 B | 1.07 B | 1.02 B | 1.03 B | 1.03 B | 1.05 B | 1.04 B | 1.13 B | 1.14 B | 1.18 B | 1.19 B | 1.25 B | 1.25 B | 1.22 B | 1.2 B | 1.24 B | 1.23 B | 1.28 B | 1.28 B | 1.33 B | 1.31 B | 1.31 B | 1.31 B | 1.31 B | 536 M | 536 M | 536 M | 536 M | 579 M | 579 M | 579 M | 579 M | 593 M | 593 M | 593 M | 593 M | 623 M | 623 M | 623 M | 623 M | 659 M | 659 M | 659 M | 659 M |
Total Shareholders Equity |
272 M | 347 M | 312 M | 266 M | 318 M | 317 M | 302 M | 293 M | 287 M | 304 M | 298 M | 303 M | 309 M | 352 M | 403 M | 412 M | 335 M | 461 M | 367 M | 342 M | - | - | - | 314 M | - | - | - | 420 M | - | - | - | 500 M | - | - | - | 550 M | - | - | - | 625 M | - | - | 384 M | 386 M | 367 M | 408 M | 386 M | 414 M | 414 M | 414 M | 414 M | 440 M | 440 M | 440 M | 440 M | 446 M | 446 M | 446 M | 446 M | 489 M | 489 M | 489 M | 489 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of CVR Partners, LP, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Agricultural inputs
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
The Mosaic Company
MOS
|
$ 22.3 | -0.25 % | $ 7.08 B |  USA |
 |
CF Industries Holdings
CF
|
$ 119.78 | 1.06 % | $ 19.4 B | USA |
 |
Акрон
AKRN
|
- | - | - |  Russia |
 |
Nutrien Ltd.
NTR
|
$ 71.48 | -0.96 % | $ 34.8 B |  Canada |
 |
Corteva
CTVA
|
$ 11.9 | -1.12 % | $ 8.09 B | USA |
 |
ФосАгро
PHOR
|
- | - | - | Russia |
 |
Yield10 Bioscience
YTEN
|
- | 15.32 % | $ 46.6 M | USA |
 |
Marrone Bio Innovations
MBII
|
- | -5.9 % | $ 180 M | USA |
 |
The Scotts Miracle-Gro Company
SMG
|
$ 64.69 | -2.56 % | $ 3.73 B | USA |
 |
Origin Agritech Limited
SEED
|
$ 0.69 | -2.51 % | $ 5.17 M |  China |
 |
Bioceres Crop Solutions Corp.
BIOX
|
$ 0.23 | 10.21 % | $ 14.5 M |  Argentina |
 |
American Vanguard Corporation
AVD
|
$ 0.96 | 0.32 % | $ 27.3 M | USA |
 |
ICL Group Ltd
ICL
|
$ 4.68 | 0.64 % | $ 6.04 B |  Israel |
 |
Intrepid Potash
IPI
|
$ 32.93 | 5.16 % | $ 429 M | USA |
 |
FMC Corporation
FMC
|
$ 5.72 | -5.69 % | $ 716 M | USA |
 |
Arcadia Biosciences
RKDA
|
$ 0.16 | -3.59 % | $ 219 K | USA |
 |
China Green Agriculture
CGA
|
- | 0.51 % | $ 27.6 M | China |